Acute responses of gastrointestinal hormones to both oral and parenteral intradialytic nutrition

American Journal of Nephrology

Volumn 32, Issue 3, 2010, Pages 272-278

  Fernández Reyes, María José ^a   Sánchez, Rosa ^a   García, Laura ^a   Grande, Cristina ^b   Codoceo, Rosa ^b   Heras, Manuel ^a   Iglesias, Pedro ^c   Velasco, Sonia ^a   Molina, Alvaro ^a   Gutierrez, Carmen ^a   Alvarez Ude, Fernando ^a  

^a HOSPITAL GENERAL DE SEGOVIA   (Spain)

^b HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^c HOSPITAL RAMÓN Y CAJAL   (Spain)

Author keywords

Ghrelin; Glucagon like peptide 1; Hemodialysis; Insulin; Intradialytic nutrition

Indexed keywords

GASTROINTESTINAL HORMONE; GHRELIN; GLUCAGON LIKE PEPTIDE 1; GLUCOSE; INSULIN;

ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; DIET THERAPY; GLUCOSE BLOOD LEVEL; HEMODIALYSIS PATIENT; HORMONE DETERMINATION; HORMONE RESPONSE; HUMAN; INSULIN BLOOD LEVEL; INTRADIALYTIC PARENTERAL NUTRITION; MALNUTRITION; NUTRITIONAL SUPPORT; PRIORITY JOURNAL;

AGED; AGED, 80 AND OVER; BLOOD GLUCOSE; DIETARY SUPPLEMENTS; ENTERAL NUTRITION; GHRELIN; GLUCAGON-LIKE PEPTIDE 1; HUMANS; INSULIN; KIDNEY FAILURE, CHRONIC; NUTRITION ASSESSMENT; NUTRITIONAL STATUS; PARENTERAL NUTRITION; PROTEIN-ENERGY MALNUTRITION; RENAL DIALYSIS;

EID: 77955546415     PISSN: 02508095     EISSN: None     Source Type: Journal    
DOI: 10.1159/000319200     Document Type: Article

References (26)

1. Pifer TB, McCullough KP, Port FK, et al: Mortality risk in hemodialysis patients and changes in nutritional indicators: DOPPS. Kidney Int 2002; 62:2238-2245.
2. Fouque D, Kalantar-Zadeh K, Kopple J, et al: A proposed nomenclature and diagnostic criteria for protein-energy wasting in acute and chronic kidney disease. Kidney Int 2008; 73: 391-398.
3. Ikizler TA: Nutrition support for the chronically wasted or acutely catabolic chronic kidney disease patient. Semin Nephrol 2009; 29: 75-84.
4. Pupim LB, Flakoll PJ, Brouillete JR, Levenhagen DK, Hakim RM, Ikizler TA: Intradialytic parenteral nutrition improves protein and energy homeostasis in chronic haemodialysis patients. J Clin Invest 2002; 110: 483-492.
5. Cano N, Fouque D, Roth H, et al: Intradialytic parenteral nutrition does not improve survival in malnourished patients: a 2-year multicentric, prospective, randomized study. J Am Soc Nephrol 2007; 18: 2583-2591.
6. Pupim LB, Majchrzak KM, Flakoll PJ, Ikizler TA: Intradialytic oral nutrition improves protein homeostasis in chronic haemodialysis patients with deranged nutritional status. J Am Soc Nephrol 2006; 17: 3149-3157.
7. Ghigo E, Broglio F, Arvat E, Macario M, Papoti M, Muccioli G: Ghrelin: more than a natural GH secretagogue and/or an orexigenic factor. Clin Endocrinol (Oxf) 2005; 62: 1-17.
8. Fouque D, Vennegoor M, Wee PT, et al: EBPG guideline on nutrition. Nephrol Dial Transplant 2007; 22(suppl 2):ii45-ii87.
9. Beddhu S, Bruns FJ, Saul M, Seddon P, Zeidel ML: A simple comorbidity scale predicts clinical outcome and cost in dialysis patients. Am J Med 2000; 108: 609-613.
10. Fiaccadori E, Parenti E, Maggiore U: Nutritional support in acute kidney injury. J Nephrol 2008; 21: 645-656.
11. Turina M, Fry DE, Polk HC: Acute hyperglycemia and the innate immune system: clinical cellular and molecular aspects. Crit Care Med 2005; 33: 1624-1633.
12. Iglesias P, Díez JJ, Fernández-Reyes MJ, et al: Serum ghrelin concentration in patients with chronic renal failure undergoing dialysis. Clinical Endocrinology (Oxf) 2006; 64: 68-73.
13. Pérez-Fontán M, Cordido F, Rodríguez-Carmona A, et al: Plasma ghrelin levels in patients undergoing haemodialysis and peritoneal dialysis. Nephrol Dial Transplant 2004; 19: 2095-2100.
14. Yoshimoto A, Mori K, Sugawara A, et al: Plasma ghrelin and desacyl ghrelin concentrations in renal failure. J Am Soc Nephrol 2002; 13: 2748-2752.
15. Shiiya T, Nakazato M, Mizuta M, et al: Plasma ghrelin levels in lean and obese humans and the effect of glucose on ghrelin secretion. J Clin Endocrinol Metab 2002;87:240-244.
16. Pérez-Fontán M, Cordido F, Rodríguez-Carmona A, et al: Acute plasma ghrelin levels and leptin response to oral feeding or intraperitoneal hypertonic glucose-based dialysate in patients with chronic renal failure. Kidney Int 2005; 68: 2877-2885.
17. Chang C, Hung C, Yen C, Hwang K, Lin C: The relationship of plasma ghrelin levels to energy regulation, feeding and ventricular function in non-diabetic haemodialysis patients. Nephrol Dial Transplant 2005; 20: 2172-2177.
18. Nakagawa E, Nagaya N, Okumura H, et al: Hyperglucemia suppresses the secretion of ghrelin, a novel growth-hormone-releasing peptide: responses to the intravenous and oral administration of glucose. Clin Sci (Lond) 2002; 103: 325-328.
19. Saad MF, Bernaba B, Hwu CM, et al: Insulin regulates plasma ghrelin concentration. J Clin Endocrinol Metab 2002; 87: 3997-4000.
20. Aguilera A, Cirujeda A, Amair R, et al: Ghrelin plasma levels and appetite in peritoneal dialysis patients. Adv Perit Dial 2004; 20:194-199.
21. Ashby DR, Ford HE, Wynne KJ, Wren AM, Murphy KG, Busbridge M, Brown EA, Taube DH, Ghatei MA, Tam FW, Bloom SR, Choi P: Sustained appetite improvement in malnourished dialysis patients by daily ghrelin treatment. Kidney Int 2009;76:199-206.
22. Deacon CF: What do we know about the secretion and degradation of incretin hormones? Regul Pept 2005; 128: 117-124.
23. Drucker D: Biological actions and therapeutic potential of the glucagon-like peptides. Gastroenterology 2002; 122: 531-544.
24. Acitores A, Gonzalez N, Sancho V, Valverde I, Villanueva- Peñacarrillo ML: Cell signalling of glucagon-like peptide-1 action in rat skeletal muscle. J Endocrinol 2004; 180: 389-398.
25. Meir J, Nauck MA, Kranz D, et al: Secretion, degradation, and elimination of glucagonlike peptide 1 and gastric inhibitory polipeptide in patients with chronic renal insufficiency and healthy control subjects. Diabetes 2004; 53: 654-662.
26. Nauck MA, Walberg J, Vethacke A, et al: Blood glucose control in healthy subjects and patients receiving intravenous glucose infusion or total parenteral nutrition using glucagon- like peptide 1. Regul Pept 2004; 118: 89-97.